Categories
AstraZeneca Pharma India Limited — Updates, 21-05-2026: General Updates
21-05-2026 · 01:29 pm
AstraZeneca Pharma India received regulatory permission to import and market Calquence® for an additional indication: untreated mantle cell lymphoma. This expands the drug's use and potential market reach in India.
No comments yet. Be the first to comment!